These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38262380)

  • 1. The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer.
    Xie B; Dong W; He F; Peng F; Zhang H; Wang W
    Oncology; 2024; 102(9):759-774. PubMed ID: 38262380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation analysis in plasma for early diagnosis in lung adenocarcinoma.
    Jin Y; Lu R; Liu F; Jiang G; Wang R; Zheng M
    Medicine (Baltimore); 2024 Jul; 103(28):e38867. PubMed ID: 38996143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
    Ji XY; Li H; Chen HH; Lin J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
    Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
    BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
    Lu H; Lin D
    Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
    Li N; Zeng Y; Huang J
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Methylation of
    Zhong Q; Wang Y; Liang C; Wei F; She B
    Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation influences the CTCF-modulated transcription of RASSF1A in lung cancer cells.
    Xie B; Peng F; He F; Cheng Y; Cheng J; Zhou Z; Mao W
    Cell Biol Int; 2022 Nov; 46(11):1900-1914. PubMed ID: 35989484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA methylation detection of SHOX2 and PTGER4 in plasma contributes to differential diagnosis of pulmonary nodule patients].
    Chu X; Zhao W; Wang B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):357-361. PubMed ID: 31167696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis.
    Ren M; Wang C; Sheng D; Shi Y; Jin M; Xu S
    Ann Diagn Pathol; 2017 Apr; 27():57-61. PubMed ID: 28325362
    [No Abstract]   [Full Text] [Related]  

  • 13. The Diagnostic Potential of
    Gao H; Yang J; He L; Wang W; Liu Y; Hu Y; Ge M; Ding J; Ye Q
    Front Oncol; 2022; 12():849024. PubMed ID: 35837113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
    Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
    J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.
    Deng Q; Su B; Ji X; Fang Q; Zhou S; Zhou C
    Cancer Biomark; 2020; 27(3):313-323. PubMed ID: 31839603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of RUNX3 and RASSF1A and the risk of Malignancy in small solitary pulmonary nodules.
    Zhao J; Cui X; Huang X; Lu R; Chen P; Zhang Z
    J Cancer Res Ther; 2019; 15(4):899-903. PubMed ID: 31436249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
    Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
    Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
    Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
    Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion.
    Chen S; Huang K; Zou L; Chen L; Hu P
    BMC Pulm Med; 2023 May; 23(1):160. PubMed ID: 37158875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.